Clinical trials
Breast Neoplasms trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
179 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 5 |
| 2006 | 14 |
| 2007 | 5 |
| 2008 | 5 |
| 2009 | 11 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 10 |
| 2015 | 8 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 12 |
| 2022 | 12 |
| 2023 | 17 |
| 2024 | 6 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 101 |
| Active, not recruiting | 36 |
| Recruiting | 18 |
| Unknown status | 10 |
| Terminated | 8 |
| Enrolling by invitation | 3 |
| Withdrawn | 1 |
| Approved for marketing | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 37 |
| AstraZeneca | 17 |
| Novartis Pharmaceuticals | 15 |
| Eli Lilly and Company | 13 |
| Pfizer | 11 |
| GlaxoSmithKline | 5 |
| Medicos e Investigadores en la Lucha contra el Cancer de Mama | 5 |
| Genentech, Inc. | 4 |
| Amgen | 3 |
| Bristol-Myers Squibb | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 179 |
| Neoplasm Metastasis | 22 |
| Neoplasms | 12 |
| Triple Negative Breast Neoplasms | 5 |
| Breast Diseases | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Neoplasms by Site | 3 |
| Prostatic Neoplasms | 3 |
| Anxiety Disorders | 2 |
| Breast Neoplasms, Male | 2 |
Trials
Showing 76 to 100 of 179. Each trial links to its page on Pharma Observatory.
79 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.